PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för palonosetron hydrochloride. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2014-08-10

Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial.

Moon HY, Baek CW, Choi GJ, Shin HY, Kang H, Jung YH, Woo YC, Kim JY, Park SG.

BMC Anesthesiol · research-article; randomized controlled trial; journal article · DOI 10.1186/1471-2253-14-68

Bibliografisk träff 2014-07-29

Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trial.

Spinelli T, Moresino C, Baumann S, Timmer W, Schultz A.

Springerplus · research-article; journal article · DOI 10.1186/2193-1801-3-389

Bibliografisk träff 2014-03-24

Effect of low concentration sodium dodecyl sulfate on the electromigration of palonosetron hydrochloride stereoisomers in micellar electrokinetic chromatography.

Hu SQ, Wang GX, Guo WB, Guo XM, Zhao M.

J Chromatogr A · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.chroma.2014.03.042

Bibliografisk träff 2014-02-20

Palonosetron exhibits higher total control rate compared to first-generation serotonin antagonists and improves appetite in delayed-phase chemotherapy-induced nausea and vomiting.

Ueda H, Shimono C, Nishimura T, Shimamoto M, Yamaue H.

Mol Clin Oncol · research-article; journal article · DOI 10.3892/mco.2014.263

Bibliografisk träff 2013-11-29

Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy.

Min JJ, Yoo Y, Kim TK, Lee JM.

Korean J Anesthesiol · research-article; journal article · DOI 10.4097/kjae.2013.65.5.397

Bibliografisk träff 2013-09-20

Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.

Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC.

Bioorg Med Chem · research-article; journal article · DOI 10.1016/j.bmc.2013.09.028

Bibliografisk träff 2013-08-01

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting.

Mori-Vogt S, Blazer M.

Expert Rev Anticancer Ther · review; journal article · DOI 10.1586/14737140.2013.814412

Bibliografisk träff 2013-04-03

Effects of Palonosetron, a 5-HT3 Receptor Antagonist, on Mechanical Allodynia in a Rat Model of Postoperative Pain.

Jung KT, Yoon MH, Lee HY, Yu BY, Kim DK, Lim KJ.

Korean J Pain · research-article; journal article · DOI 10.3344/kjp.2013.26.2.125

Bibliografisk träff 2013-03-08

The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting.

Huang J, Wang XJ, Yu D, Jin YN, Zhen LZ, Xu N, Liu W, Deng YC, Wu SX, He J.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2013.996

Bibliografisk träff 2013-02-18

An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.

Fabi A, Malaguti P.

Expert Opin Pharmacother · systematic review; journal article · DOI 10.1517/14656566.2013.771166

Bibliografisk träff 2013-01-26

Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial.

Boccia R, Grunberg S, Franco-Gonzales E, Rubenstein E, Voisin D.

Support Care Cancer · clinical trial, phase iii; comparative study; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1007/s00520-012-1691-5